Zami Aberman - Director, Pluristem Therapeutics Inc
As of February 14, 2022
Zami Aberman Net Worth
- Net worth is estimated to be at least $3.21M
- Owns at least 1,585,729 units of Pluristem Therapeutics Inc stock
- Sold an estimated value of $742.39K in the last 15 years at Pluristem Therapeutics Inc
Zami Aberman Compensation at Pluristem Therapeutics Inc in 2020
- Earned a $439,704 salary
- Received a total compensation of $501,244
Zami Aberman Trading
- Largest purchase of shares was 80,616 units , worth over $145.11K on February 14, 2022
- Largest sale of shares was 69,850 units , worth over $299.98K on January 14, 2014
- In total has made about 36 transactions over 15 years
- Usually trades in September and December, with the busiest year in 2014
Zami Aberman
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
Zami Aberman Mailing Address
- Mailing address is 63 Rabutzky Street Raanana L3 43220 Israel
Pluristem Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|
| Zami Aberman | 2020 | $439,704 | - | $61,540 | $501,244 |
| Zami Aberman | 2019 | $551,137 | $478,500 | $66,857 | $1,096,494 |
| Yaky Yanay | 2020 | $320,911 | - | $29,466 | $350,377 |
| Yaky Yanay | 2019 | $396,632 | $461,100 | $29,253 | $886,985 |
| Chen Franco-Yehuda | 2020 | $179,229 | - | $28,461 | $207,690 |
| Chen Franco-Yehuda | 2019 | $78,889 | $112,329 | $13,599 | $204,817 |
| No matching records found | |||||
Source: https://www.sec.gov/Archives/edgar/data/1158780/000121390021020786/ea139144-def14a_pluristem.htm
Pluristem Therapeutics Inc Insider Trading
- The most recent transaction was 80,616 units bought on February 14, 2022 by Zami Aberman worth over $145.11K
- In the last 14 years, insiders at Pluristem Therapeutics Inc sold an estimated value of $7.29M and bought an estimated value of $14.34M
- The most active traders are Zami Aberman, Director, Yaky Yanay, CEO & President, and Israel Ben-Yoram, Director
- Insider trading is most common in December, with the busiest year in 2009
PLURISTEM THERAPEUTICS INC Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||